D68.312 - Antiphospholipid antibody with hemorrhagic disorder
- Applicable to Antiphospholipid antibody with hemorrhagic disorder
- The 2025 edition of ICD10-CM D68.312 became effective on October 1, 2024.
- This is the American ICD10-CM version of D68.312 - other international versions of ICD10 D68.312 may differ.
- D68.312 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion Term
- Lupus anticoagulant (LAC) with hemorrhagic disorder
- Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
Type 1 Excludes
- antiphospholipid antibody, finding without diagnosis (R76.0)
- antiphospholipid antibody syndrome (D68.61)
- antiphospholipid antibody with hypercoagulable state (D68.61)
- lupus anticoagulant (LAC) finding without diagnosis (R76.0)
- lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
- systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
- systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
The following codes above D68.312 contain annotation back-references that may be applicable to D68.312:
Section: D65-D69 Coagulation defects, purpura and other hemorrhagic conditions
Category: D68 Other coagulation defects
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com